NCT06326229 Clinical Validation of Musculoskeletal ICF Core Set in Primary Care Physiotherapy
| NCT ID | NCT06326229 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Valladolid |
| Condition | Musculoskeletal Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 385 participants |
| Start Date | 2024-06-17 |
| Primary Completion | 2025-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 385 participants in total. It began in 2024-06-17 with a primary completion date of 2025-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this observational study is to validate the content of a tailored ICF core set for the management of musculoskeletal conditions in primary care physiotherapy services. The main question it aims to answer is: \- Are the ICF entities included in the ICF Core Set under evaluation useful from a clinical point of view? Participants will evaluate the relevance of each ICF entity included in the ICF core set according to their musculoskeletal condition.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or older * Patients diagnosed with a musculoskeletal condition by a general practitioner * Patients with adequate knowledge of the Spanish language Exclusion Criteria: * Patients referred for a non-musculoskeletal problem * Patients referred from hospital services
Contact & Investigator
Sandra Jiménez del Barrio, PhD
STUDY CHAIR
University of Valladolid
Frequently Asked Questions
Who can join the NCT06326229 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Musculoskeletal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06326229 currently recruiting?
Yes, NCT06326229 is actively recruiting participants. Contact the research team at hhernandezl@saludcastillayleon.es for enrollment information.
Where is the NCT06326229 trial being conducted?
This trial is being conducted at Ólvega, Spain.
Who is sponsoring the NCT06326229 clinical trial?
NCT06326229 is sponsored by University of Valladolid. The principal investigator is Sandra Jiménez del Barrio, PhD at University of Valladolid. The trial plans to enroll 385 participants.